Sign up to save your podcasts
Or
Share Breakpoints
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Breakpoints episodes
- #30 – Is More Better? The Role of Combination Therapy for MRSA
Host Erin McCreary (@erinmccreary) and expert panelists Dr. Katie Barber (@IDKatieBarb), Dr. Warren Rose (@Warren_E_Rose), and Dr. Steven Tong (@syctong) discuss data from early laboratory work to randomized, clinical trials for various antibiotic combinations used in the treatment of MRSA bacteremia. This was our most requested topic to cover on Breakpoints, and we hope you enjoy!
Please complete this brief survey to help us continue to improve Breakpoints content: https://docs.google.com/forms/d/e/1FAIpQLSeriW-TAgiBik2_gdJllCZ4WqADhUyFIZtTAgYAYxRU5YU3hA/viewform?vc=0&c=0&w=1&flr=0
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/1 hr 2 min - #29 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) discuss notable infectious diseases publications from the first half of 2020.
Papers discussed:
1) Van Duin D, et al. Lancet Infect Dis. 2020 Jun;20(6):731-741. doi: 10.1016/S1473-3099(19)30755-8.
2) Livermore DM, et al. Clin Infect Dis. 2020 Feb 6;ciaa122. doi: 10.1093/cid/ciaa122.3) Falcone M, et al. Clin Infect Dis. 2020 May 19;ciaa586. doi: 10.1093/cid/ciaa586.4) Lodise TP, et al. J Antimicrob Chemother. 2020 May 28;dkaa197. doi: 10.1093/jac/dkaa197.5) O’Donnell JN, et al. Clin Ther. 2020 Jul 16;S0149-2918(20)30315-5. doi: 10.1016/j.clinthera.2020.06.005.6) Abdul-Aziz MH, et al. Intensive Care Med. 2020 Jun;46(6):1127-1153. doi: 10.1007/s00134-020-06050-1.7) Cusumano JA, et al. Am J Health Syst Pharm. 2020 Jul 7;77(14):1104-1112. doi: 10.1093/ajhp/zxaa128.8) Roberts JA, et al. Clin Infect Dis. 2020 Mar 9;ciaa224. doi: 10.1093/cid/ciaa224.9) Ackerman A, et al. Antimicrob Agents Chemother. 2020 May 21;64(6):e00066-20. doi: 10.1128/AAC.00066-20.10) Tong SYC, et al. JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103.11) Jones BE, et al. JAMA Intern Med. 2020 Feb 17;180(4):552-560. doi: 10.1001/jamainternmed.2019.7495.12) Cheng MP, et al. Clin Infect Dis. 2020 Jul 15;ciaa1000. doi: 10.1093/cid/ciaa1000.For BCIDP credit, visit https://sidp.org/BCIDP
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/1 hr 18 min - #28 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) discuss notable infectious diseases publications from the first half of 2020!
Papers discussed:
1) Rybak MJ, et al. Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
2) Scheetz MH. Am J Health Syst Pharm. 2020 May 19;77(11):810-811. doi: 10.1093/ajhp/zxaa076.3) Alosaimy S, et al. Clin Infect Dis. 2020 July 27;ciaa1039. doi: 10.1093/cid/ciaa1039.4) Rhee C, et al. Clin Infect Dis. 2020 May 6;ciaa059. doi: 10.1093/cid/ciaa059.5) Heil EL, et al. Pharmacotherapy. 2020 Apr;40(4):368-371. doi: 10.1002/phar.2384.6) Townsend SR, et al. Clin Infect Dis. 2020 May 6;ciaa458. doi: 10.1093/cid/ciaa458.7) Satlin MJ, et al. Clin Infect Dis. 2020 Feb 13;ciaa121. doi: 10.1093/cid/ciaa121.8) Pogue JM, et al. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01495-19. doi: 10.1128/AAC.01495-19.9) Ambrose PG, et al. Open Forum Infect Dis. 2020 Mar 13;7(7):ofaa084. doi: 10.1093/ofid/ofaa084.10) Singh N, et al. JAMA. 2020 Apr 14;323(14):1378-1387. doi: 10.1001/jama.2020.3138.11) van Delden C, et al. Clin Infect Dis. 2020 Jan 9;ciz1113. doi: 10.1093/cid/ciz1113.12) Niederman MS, et al. Lancet Infect Dis. 2020 Mar;20(3):330-340. doi: 10.1016/S1473-3099(19)30574-2.13) von Dach E, et al. JAMA. 2020 Jun 2;323(21):2160-2169. doi: 10.1001/jama.2020.6348.14) Mergenhagen KA, et al. Antimicrob Agents Chemother. 2020 Feb 21;64(3):e02167-19. doi: 10.1128/AAC.02167-19.For BCIDP credit, visit https://sidp.org/BCIDP
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/1 hr 15 min - #27 – Expert Updates in Gram Negative Resistance: Q&A Session
This is part 2 of a continuing education series produced in partnership with the SIDP Education Center (SIDPEC) on gram-negative bacterial resistance. It features expert speakers, Drs. Keith Kaye (@Keith_S_Kaye) and Kimberly Claeys (@ClaeysKcclaeys) and host Julie Ann Justo (@julie_justo). If you missed part 1 of this series, delivered as a webinar lecture, please go to sidp.org/SIDPEC to view that portion of the series first. In this podcast, our experts answer a collation of > 150 questions from interested viewers on the nuances of gram-negative bacterial resistance, from real-world formulary considerations to microbiology lab implementation and more.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/1 hr 18 min - #26 – OPAT - The Final Frontier, Part 2
Gain insight into Outpatient Parenteral Antibiotic Therapy (OPAT) practices across the country from Drs. Jessie Ortwine (@jkortwine), Monica Mahoney (@mmpharmd), Keenan Ryan (@keenanconazole), Monica Donnelley (@DonnelleyMonica), and Meera Mehta.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/32 min - #25 – Remdesivir: Ethical and Practical Considerations for Allocation, Tracking, and More
Drs. Julie Ann Justo (@julie_justo), Erin McCreary (@erinmccreary), and Helen Newland (@helennewland) discuss ethical allocation of Emergency Use Authorization remdesivir for patients with COVID-19.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/1 hr 17 min - #24 – OPAT – The Final Frontier, Part 1
Gain insight into Outpatient Parenteral Antibiotic Therapy (OPAT) practices across the country from Drs. Jessie Ortwine (@jkortwine), Monica Mahoney (@mmpharmd), Keenan Ryan (@keenanconazole), Monica Donnelley (@DonnelleyMonica), and Meera Mehta.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/26 min - #23 – Taking a “BITE” Out of Antibiotic Prescribing: Strategies to Improve Antimicrobial Usage in Dentistry
Dr. Katie Suda (@sudamonas) and Dr. Erinne Kennedy join Dr. Zahra Escobar (@zkepharmd) of the Breakpoints team to discuss strategies to improve antibiotic utilization and forge connections with our dental colleagues to achieve a common goal of improved patient outcomes.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/34 min - #22 – Taking a “BITE” Out of Antibiotic Prescribing: The Need for Antimicrobial Stewardship in Dentistry
Dr. Katie Suda (@sudamonas) and Dr. Erinne Kennedy join Dr. Zahra Escobar (@zkepharmd) of the Breakpoints team to discuss why dentists prescribe 1 in 10 of all antibiotics in the United States and how COVID-19 risks are being managed among dentists and other oral health providers.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/38 min - #21 – Frontline Allies: Emergency Medicine and Critical Care Insights into COVID19
Dr. Jenny Koehl (@jlkoehl), Dr. Karen Berger (@karenccrx), and Dr. Karen Dohr join host Erin McCreary (@erinmccreary) to discuss taking care of patients with COVID-19 in the Emergency Department and Intensive Care Unit. Listen as the team reflects on their first patients, PPE, anticoagulation, corticosteroid controversies, and more!
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)Facebook: https://www.facebook.com/sidprxLinkedIn: https://www.linkedin.com/company/sidp/1 hr 2 min
About Breakpoints
From the publisher's feed
The SIDP Podcast
More shows like Breakpoints
NEJM This Week
319 Listeners
This Week in Virology
2,052 Listeners
JAMA Clinical Reviews
496 Listeners
Let's Talk ID
129 Listeners
The Curbsiders Internal Medicine Podcast
3,343 Listeners
Core IM | Internal Medicine Podcast
1,157 Listeners
The Clinical Problem Solvers
520 Listeners
Critical Care Scenarios
256 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
Febrile
190 Listeners
ID:IOTS - Infectious Disease Insight Of Two Specialists
29 Listeners
Infectious Disease Puscast
92 Listeners
Critical Care Time
270 Listeners
Communicable
4 Listeners
Joint Approach
10 Listeners